We help biotech companies expand their definition of “medical device” to fit the FDA’s inclusion of cloud technology more closely.
This has the effect of re-architecting their product and company to take full advantage of the Cloud's strength, enabling them to achieve high levels of work efficiency, cost-effectiveness, and profitability.